Emerging motor dysfunction in those at-risk of Parkinson’s disease: 5-year follow-up of PREDICT-PD participants
Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…Advance Care Planning in Complex Stage Parkinson’s Disease
Objective: Advance Care Planning (ACP) in patients with Complex stage Parkinson’s disease (PD) at the Royal Berkshire Foundation Trust (RBFT),Reading,United Kingdom. Background: In April 2019,…Role of Sex in Parkinson’s Disease Progression
Objective: To investigate the sex differences for disease progression in Parkinson’s disease (PD). Background: Prevalence and symptom profile in PD differ between women and men.…Correlation of brain activity measured using quantitative electroencephalography and cognitive function in patients with de novo Parkinson’s disease
Objective: We performed an exploratory analysis of the correlation of brain activity measured using qEEG and early cognitive function in patients with de novo PD.…Does age at onset of Parkinson’s disease affect the development of dementia?
Objective: To investigate whether progression to dementia in senile Parkinson’s disease, SPD, (disease onset after 70 years) differs from that in old Parkinson’s disease, OPD,…A Fluctuating Qualitative Dermatoglyphic Trait, Dankmeijer’s and Furuhata’s Index as a Risk Marker in Diabetic Parkinson’s Patients of Guyana: A Case-Control Study
Objective: The current study aims to compare and evaluate the fluctuating qualitative dermatoglyphic trait, Furuhata’s and Dankmeijer’s index as a risk marker in Diabetes and…Identification of Parkinson’s disease predisposition genes in high-risk pedigrees
Objective: To identify families with an increased risk of Parkinson’s disease (PD) and the gene variants associated with such increased disease risk studying large multi-generation…Alpha-synuclein and Amyloid beta peptide 1-42 in Parkinson’s disease and parkinsonian plus syndrome cohorts
Objective: To evaluate the serum levels of α-synuclein (α-syn) and Amyloid β 1-42 (Aβ1-42) in the patients of Parkinson’s disease (PD), progressive supranuclear palsy (PSP)…Body weight and brainstem raphe echogenicity in patients with Parkinson’s disease
Objective: We aimed to investigate and compare of body weight between normal and abnormal BR echogenicity in patients with PD. Background: Weight loss is frequent…Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism
Objective: To investigate neural correlates associated with olfactory dysfunction using fMRI and EEG in Parkinsonism. Background: Patients with Parkinsonism experience non-motor symptoms during the onset…
- « Previous Page
- 1
- …
- 95
- 96
- 97
- 98
- 99
- …
- 425
- Next Page »